Goldman Sachs Group Inc. lifted its position in shares of Genesis Healthcare, Inc. (NYSE:GEN) by 6.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 90,612 shares of the company’s stock after acquiring an additional 5,250 shares during the quarter. Goldman Sachs Group Inc. owned 0.11% of Genesis Healthcare worth $158,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in GEN. Bank of New York Mellon Corp boosted its stake in shares of Genesis Healthcare by 2.4% during the 1st quarter. Bank of New York Mellon Corp now owns 229,770 shares of the company’s stock worth $607,000 after acquiring an additional 5,451 shares in the last quarter. Alliancebernstein L.P. raised its position in shares of Genesis Healthcare by 2.6% during the 1st quarter. Alliancebernstein L.P. now owns 83,126 shares of the company’s stock worth $219,000 after purchasing an additional 2,100 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Genesis Healthcare by 50.1% during the 1st quarter. TIAA CREF Investment Management LLC now owns 223,085 shares of the company’s stock worth $589,000 after purchasing an additional 74,502 shares during the last quarter. California Public Employees Retirement System raised its position in shares of Genesis Healthcare by 12.5% during the 1st quarter. California Public Employees Retirement System now owns 262,500 shares of the company’s stock worth $693,000 after purchasing an additional 29,100 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in shares of Genesis Healthcare by 116.3% during the 1st quarter. Renaissance Technologies LLC now owns 687,000 shares of the company’s stock worth $1,814,000 after purchasing an additional 369,400 shares during the last quarter. 15.86% of the stock is currently owned by institutional investors and hedge funds.

Separately, Royal Bank Of Canada restated a “hold” rating and set a $2.00 price objective on shares of Genesis Healthcare in a research report on Wednesday, September 13th.

TRADEMARK VIOLATION NOTICE: “Genesis Healthcare, Inc. (GEN) Shares Bought by Goldman Sachs Group Inc.” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & international copyright law. The original version of this article can be viewed at https://www.watchlistnews.com/genesis-healthcare-inc-gen-shares-bought-by-goldman-sachs-group-inc/1721128.html.

Genesis Healthcare, Inc. (NYSE:GEN) opened at $0.87 on Thursday. The company has a debt-to-equity ratio of -0.22, a quick ratio of 0.18 and a current ratio of 0.18. Genesis Healthcare, Inc. has a 12-month low of $0.84 and a 12-month high of $4.75.

About Genesis Healthcare

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.